Learn more

IGNYTA INC

Overview
  • Total Patents
    178
  • GoodIP Patent Rank
    9,683
  • Filing trend
    ⇧ 16.0%
About

IGNYTA INC has a total of 178 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BAGO SA LABOR, NFLECTION THERAPEUTICS INC and BIOMARIN IGA LTD.

Patent filings per year

Chart showing IGNYTA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hudkins Robert L 47
#2 Zulli Allison L 26
#3 Li Gang 18
#4 Drager Anthony S 17
#5 Labell Rachel Y 17
#6 Roemmele Renee C 17
#7 Brown Peter D 17
#8 Bakale Roger P 17
#9 Lim Jonathan 17
#10 Patel Piyush R 17

Latest patents

Publication Filing date Title
CN111225662A Pharmaceutical compositions and dosage forms
KR20200031115A Pharmaceutical composition comprising entretinib
WO2018102455A1 Methods for the treatment of cancer
US2019224200A1 Combinations for the treatment of cancer
US2019185567A1 Combinations for the treatment of cancer
MX2018007266A Combinations for the treatment of cancer.
CN108495862A Topical formulations
EP3303382A1 Compositions and methods for treating patients with rtk mutant cells
US2017356918A1 Multiplexed immunohistochemistry assays for diagnosis and treatment of cancer
KR20170094259A Combinations for the treatment of neuroblastoma
WO2015199939A1 Compositions and methods for amplifying and determining nucleic acid sequences
TW201623300A Azaquinazoline inhibitors of atypical protein kinase c
TW201613593A Molecules for administration to ros1 mutant cancer cells
CA2934667A1 Pyrazolo[1,5-a]pyridine derivatives and methods of their use
WO2014189787A2 Compositions and methods for the determination of methylation status
EA025561B1 Solid state forms of a quinazoline derivative and its use as a braf inhibitor
KR20150086308A Bendamustine derivatives and methods of using same
WO2014036314A2 Diagnosis of rheumatoid arthritis (ra) using differentially methylated loci identified in peripheral blood mononuclear cells, t-cells, b-cells and monocytes
WO2014008426A2 Diagnosis of systemic lupus erythematosus